Pharmaceutical Executive Europe - January 2008 - (Page 3)
Pharmaceutical Executive Europe January 2008 Contents 3 Pharmaceutical Executive Advancing business leadership www.pharmexeceurope.com Corporate Strategy Walking the Line Brian D. Smith There is more to innovation than invention and insight. And how do good firms make it pay? page 14 Executive Profile The Pharmacist’s Friend Pharm Exec Europe Gary Noon, Aegate CEO, talks about the new role of the pharmacist in the future of patient safety. page 18 Q&A An End to Drug Counterfeiting Ton van Lierop Interview with an official from the cabinet of EC vice president Günter Verheugen. page 20 Healthcare Cost Assessment Ready to Make NICE? François Lucas Perspectives on the growing number of countries implementing cost-effectiveness evaluations. page 22 Pricing and Reimbursement Generics Through the Reimbursement Barriers India Inc. Brian Lovatt How can cancer drug development companies clear the pricing and reimbursement hurdles? page 25 Urmila Doraswami and Edwin Bailey How Indian companies are fully exploiting the significant growth of the generics market. page 28 Regulars From the Editor A NICE change News and Analysis Calendar 4 6 12 The Mix New Models of Excellence S. Danner, A. Ruzicic and M. Oelschlegel In these turbulent times, commercial excellence is the best way for pharma companies to survive. page 31 Last Word Mid-size Matters Luciano Conde Are mid-size pharma companies best positioned to succeed in today’s market? page 35
http://www.pharmexeceurope.com
Table of Contents for the Digital Edition of Pharmaceutical Executive Europe - January 2008